Imricor Medical (Australia) Insiders
| IMR Stock | 1.16 0.06 5.45% |
Imricor Medical employs about 7 people. The company is managed by 7 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Imricor Medical's management performance can provide insight into the firm performance.
| Steve Wedan CEO CEO President |
| Steven Wedan CEO CEO President |
Imricor |
Imricor Medical Management Team Effectiveness
The company has return on total asset (ROA) of (1.2467) % which means that it has lost $1.2467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7456) %, meaning that it generated substantial loss on money invested by shareholders. Imricor Medical's management efficiency ratios could be used to measure how well Imricor Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Imricor Medical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 15.9 M in 2024, despite the fact that Change To Liabilities is likely to grow to (489.8 K).Common Stock Shares Outstanding is likely to drop to about 128.8 M in 2024. Net Loss is likely to drop to about (16.4 M) in 2024
Imricor Medical Workforce Comparison
Imricor Medical Systems is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 17,826. Imricor Medical adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Imricor Medical Systems Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Imricor Medical Systems Price Series Summation is a cross summation of Imricor Medical price series and its benchmark/peer.
Imricor Medical Notable Stakeholders
An Imricor Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Imricor Medical often face trade-offs trying to please all of them. Imricor Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Imricor Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Steve Wedan | CEO President | Profile | |
| Steven Wedan | CEO President | Profile | |
| Jonathon Gut | Controller, CFO | Profile | |
| Gregg Stenzel | Chief Officer | Profile | |
| Nick Twohy | Vice Development | Profile | |
| Greg Englehardt | Senior Sales | Profile | |
| Kobe Lizheng | Company Agent | Profile |
About Imricor Medical Management Performance
The success or failure of an entity such as Imricor Medical Systems often depends on how effective the management is. Imricor Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Imricor management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Imricor management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Imricor Medical is entity of Australia. It is traded as Stock on AU exchange.
Please note, the imprecision that can be found in Imricor Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Imricor Medical Systems. Check Imricor Medical's Beneish M Score to see the likelihood of Imricor Medical's management manipulating its earnings.
Imricor Medical Workforce Analysis
Traditionally, organizations such as Imricor Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Imricor Medical within its industry.Imricor Medical Manpower Efficiency
Return on Imricor Medical Manpower
| Revenue Per Employee | 87.9K | |
| Revenue Per Executive | 87.9K | |
| Net Loss Per Employee | 4.9M | |
| Net Loss Per Executive | 4.9M |
Additional Tools for Imricor Stock Analysis
When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.